ロード中...
Castration-Resistant Prostate Cancer: Mechanisms, Targets, and Treatment
Patients with castration-resistant prostate cancer (CRPC), who progress after docetaxel therapy, had until very recently, only a few therapeutic options. Recent advances in this field brought about new perspectives in the treatment of this disease. Molecular, basic, and translational research has gi...
保存先:
| 主要な著者: | , , , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Hindawi Publishing Corporation
2012
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3316959/ https://ncbi.nlm.nih.gov/pubmed/22530130 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2012/327253 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|